Multiple Sclerosis Clinical Trials near Chicago, IL
20 studies for Multiple Sclerosis are recruiting at 24 sites within 50 miles of Chicago, Illinois, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Multiple Sclerosis trials in the US or all trials near Chicago.
Recruiting now
Multiple Sclerosis studies enrolling near Chicago
- A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
NCT06433752
- Observational
- Ages 18 years and older
- Sex: All
Nearest sites: TG Therapeutics Investigational Trial Site (Chicago, IL); TG Therapeutics Investigational Trial Site (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
NCT06846281
- Phase 3
- Ages 40 to 70 years
- Sex: All
Nearest sites: Rush University Medical Center (Chicago, IL); University of Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
NCT07002034
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest sites: Rush University Medical Center (Chicago, IL); University of Chicago Medical Center (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
NCT05051618
- Interventional
- Ages 18 to 64 years
- Sex: All
Nearest site: University of Illinois at Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Nomad P-KAFO Study
NCT05644522
- Interventional
- Ages 18 to 89 years
- Sex: All
Nearest site: Shirley Ryan AbilityLab (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
NCT05877963
- Phase 3
- Ages 18 to 65 years
- Sex: All
Nearest site: TG Therapeutics Investigational Trial Site (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Intermittent Hypoxia in Persons With Multiple Sclerosis
NCT06276634
- Interventional
- Ages 18 to 75 years
- Sex: All
Nearest site: Shirley Ryan AbilityLab (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Functional Balance Intervention in Multiple Sclerosis
NCT06341023
- Interventional
- Ages 18 to 90 years
- Sex: All
Nearest site: University of Illinois at Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
NCT06390930
- Interventional
- Ages 18 to 75 years
- Sex: All
Nearest site: Shirley Ryan AbilityLab (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
NCT06408259
- Phase 3
- Ages 10 to 17 years
- Sex: All
Nearest site: University of Chicago Medical Center (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device
NCT06410261
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: University of Illinois at Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain
NCT07132775
- Interventional
- Ages 18 to 75 years
- Sex: All
Nearest site: Shirley Ryan AbilityLab (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
NCT07207148
- Observational
- Ages 18 to 70 years
- Sex: All
Nearest site: Northwestern Memorial Hospital (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
NCT07225361
- Phase 4
- Ages 18 to 70 years
- Sex: All
Nearest site: Northwestern Memorial Hospital (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
NCT07225504
- Phase 3
- Ages 18 to 65 years
- Sex: All
Nearest site: Northwestern Memorial Hospital (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Home Based Functional Balance Intervention for Multiple Sclerosis
NCT07355387
- Interventional
- Ages 40 to 90 years
- Sex: All
Nearest site: University of Illinois at Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- The Effect of Remotely Delivered Pilates on Physical , and Psychological Outcomes in Individuals With Multiple Sclerosis
NCT07504120
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: University of Illinois Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Ocrevus Zunovo for MS: Mixed Methods
NCT07710105
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: Northwestern Memorial Hospital (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
NCT04047628
- Phase 3
- Ages 18 to 55 years
- Sex: All
Nearest site: Northwestern University (Evanston, IL)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
NCT07325292
- Phase 3
- Ages 18 to 60 years
- Sex: All
Nearest site: Consultants in Neurology- Site Number : 8400020 (Northbrook, IL)
- Distance to nearest recruiting site
- ~21 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a Multiple Sclerosis clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.